Risk Factors in Carbapenem Resistant Enterobacteriaceae Infections
, 2020 Carbapenem resistance, which was rarely observed up until the recent years, is becoming increasingly more common among the Enterobacteriaceae family around the world. It is thought that specifying the risk factors for carbapenem-resistant Enterobacteriaceae (CRE) infections may be helpful to initiate the appropriate empirical therapy at an early phase ...
Saim Dayan +6 more
openaire +2 more sources
The difficult-to-control spread of carbapenemase producers in Enterobacteriaceae worldwide [PDF]
, 2014 Spread of carbapenemase producers in Enterobacteriaceae is now identified worldwide. Three main carbapenemases are reported which belong to three classes of ß-lactamases that are KPC, NDM and OXA-48.
Nordmann, Patrice, Poirel, Laurent
core
Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
Antibiotics, 2019 Carbapenem-resistant Enterobacteriaceae (CRE) have become a public health threat worldwide. There are three major mechanisms by which Enterobacteriaceae become resistant to carbapenems: enzyme production, efflux pumps and porin mutations.
Beatriz Suay-García +1 more
doaj +1 more source
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy [PDF]
, 2014 Pierluigi Viale +16 more
openalex +1 more source
Thirty-Day Laboratory-Based Surveillance for Carbapenem-Resistant Enterobacteriaceae in the Minneapolis-St. Paul Metropolitan Area [PDF]
, 2014 Edwin C. Pereira +6 more
openalex +1 more source
2025 ACVIM Forum Research Report Program
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley +1 more source
1399Laboratory Characterization and Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) in Hennepin and Ramsey Counties, Minnesota, 2012-2013 [PDF]
, 2014 Melissa Hargreaves +5 more
openalex +1 more source
Four Cases of Carbapenem-ResistantEnterobacteriaceaeInfection from January to March in 2014 [PDF]
, 2015 So Ri Kim +7 more
openalex +1 more source
Polymyxin b therapy for multidrug resistant gram negative infections : outcome and risk factors for treatment failure in critical care [PDF]
, 2015 Objective: Polymyxins have re-administered in clinical practice due to the dry antibiotic development pipeline and worldwide increasing infections caused by multi-drug resistant (MDR) gram negative bacteria.
Ismail, Bahiah
core
369Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae [PDF]
Open Forum Infectious Diseases, 2014 Mashashi Waga +6 more
openaire +2 more sources